Navigation Links
Breast Cancer Rates Lower With Less Hormone Therapy: Study
Date:11/30/2010

TUESDAY, Nov. 30 (HealthDay News) -- Reduced use of hormone replacement therapy (HRT) is linked to declines in rates of invasive breast cancer and ductal carcinoma in situ, the most common form of noninvasive breast cancer, a new study reports.

The University of California, San Francisco, study included nearly 700,000 women, aged 40 to 79, who underwent more than 2 million screening mammography examinations between January 1997 and December 2008.

Women aged 50 to 69 had the highest level of hormone therapy use and also had the largest reduction in invasive breast cancer when they stopped hormone therapy -- from 40 cancers per 10,000 mammograms in 2002 to 31 cancers in 2005, and 35 cancers in 2006, the investigators found.

The study also found a sharp drop in rates of ductal carcinoma in situ in this age group after they stopped using hormone therapy.

A parallel decrease in these types of breast cancer also occurred among women older than 70. However, there was no change in breast cancer rates during the study period among women aged 40 to 49, who were less likely to have been on hormone therapy.

The researchers said their findings suggest that hormone therapy helped promote breast cancer tumor growth.

"We show that the incidence of breast cancer decreases if you take the hormones away. The fact that we're continuing to see a decrease in invasive [breast] cancer means that the effects of stopping the hormones may be long-lasting," senior author Dr. Karla Kerlikowske said in a university news release.

The study was released online in advance of publication in an upcoming print issue of the Journal of Clinical Oncology.

More information

The U.S. National Cancer Institute has more about hormone replacement therapy and cancer.

-- Robert Preidt

SOURCE: University of California, San Francisco, news release, Nov. 29, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Rates Lower With Less Hormone Therapy: Study
(Date:5/4/2016)... ... 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic ... LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her computer, riding ... same day as her in-office consultation and eye exam. Francesca’s eyesight was restored to ...
(Date:5/4/2016)... ... 2016 , ... Natalie Jill is a well respected lifestyle mentor ... the launch of her new book: Natalie Jill’s 7 Day Jump Start: Unprocess Your ... jump start a new healthy lifestyle featuring simple recipes using MitoXcell’s raw cacao formula. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... pharmacy industry, today announced that it was chosen as the Pharmaceutical News Provider ... Awards . The awards acknowledge the hard work and dedication of community members ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare facility Pearl ... following breast cancer surgery. In March 2016, the 61-year-old model and reality TV star ... that occurs in the milk ducts, according to an interview with the Daily ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... multi-function small and compact tactical (6.7 inch) dual-light flashlights in models NSP-9842XL ... model NSP-9842XL (average retail starting at $59.95) uses 2 included CR-123 batteries to ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Multiple Myeloma Market ... to their offering.       (Logo: ... Myeloma Market and Competitive Landscape Highlights 2016, ... products, Multiple Myeloma epidemiology, Multiple Myeloma market ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Ischemic Stroke Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Ischemic Stroke Market and Competitive Landscape Highlights ... Stroke pipeline products, Acute Ischemic Stroke epidemiology, ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
Breaking Medicine Technology: